260 related articles for article (PubMed ID: 21909081)
1. Postradiation cutaneous angiosarcoma after treatment of breast carcinoma is characterized by MYC amplification in contrast to atypical vascular lesions after radiotherapy and control cases: clinicopathological, immunohistochemical and molecular analysis of 66 cases.
Mentzel T; Schildhaus HU; Palmedo G; Büttner R; Kutzner H
Mod Pathol; 2012 Jan; 25(1):75-85. PubMed ID: 21909081
[TBL] [Abstract][Full Text] [Related]
2. MYC amplification and overexpression in primary cutaneous angiosarcoma: a fluorescence in-situ hybridization and immunohistochemical study.
Shon W; Sukov WR; Jenkins SM; Folpe AL
Mod Pathol; 2014 Apr; 27(4):509-15. PubMed ID: 24091875
[TBL] [Abstract][Full Text] [Related]
3. [MYC amplification distinguishes between atypical vascular lesion and radiation-induced angiosarcoma of the breast].
Hafner C
Hautarzt; 2013 Jul; 64(7):533-4. PubMed ID: 23744032
[No Abstract] [Full Text] [Related]
4. Angiosarcoma and atypical vascular lesions of the breast: diagnostic and prognostic role of MYC gene amplification and protein expression.
Fraga-Guedes C; André S; Mastropasqua MG; Botteri E; Toesca A; Rocha RM; Peradze N; Rotmensz N; Viale G; Veronesi P; Gobbi H
Breast Cancer Res Treat; 2015 May; 151(1):131-40. PubMed ID: 25893585
[TBL] [Abstract][Full Text] [Related]
5. MYC gene amplification by fluorescence in situ hybridization and MYC protein expression by immunohistochemistry in the diagnosis of cutaneous angiosarcoma: Systematic review and appropriate use criteria.
Motaparthi K; Lauer SR; Patel RM; Vidal CI; Linos K
J Cutan Pathol; 2021 Apr; 48(4):578-586. PubMed ID: 33128474
[TBL] [Abstract][Full Text] [Related]
6. Can c-myc amplification reliably discriminate postradiation from primary angiosarcoma of the breast?
Laé M; Lebel A; Hamel-Viard F; Asselain B; Trassard M; Sastre X; Kirova YM
Cancer Radiother; 2015 May; 19(3):168-74. PubMed ID: 25863565
[TBL] [Abstract][Full Text] [Related]
7. Immunohistochemical and Fluorescence In Situ Hybridization Analysis of MYC in a Series of 17 Cutaneous Angiosarcomas: A Single-Center Study.
Requena C; Rubio L; Lavernia J; Machado I; Llombart B; Sanmartín O; Traves V; Guillén C; Cruz J
Am J Dermatopathol; 2018 May; 40(5):349-354. PubMed ID: 29135507
[TBL] [Abstract][Full Text] [Related]
8. Fully automated dual-color dual-hapten silver in situ hybridization staining for MYC amplification: a diagnostic tool for discriminating secondary angiosarcoma.
Ko JS; Billings SD; Lanigan CP; Buehler D; Fernandez AP; Tubbs RR
J Cutan Pathol; 2014 Mar; 41(3):286-92. PubMed ID: 24329959
[TBL] [Abstract][Full Text] [Related]
9. Reduced H3K27me3 expression in radiation-associated angiosarcoma of the breast.
Mentzel T; Kiss K
Virchows Arch; 2018 Mar; 472(3):361-368. PubMed ID: 28983701
[TBL] [Abstract][Full Text] [Related]
10. Diagnostic utility of MYC amplification and anti-MYC immunohistochemistry in atypical vascular lesions, primary or radiation-induced mammary angiosarcomas, and primary angiosarcomas of other sites.
Ginter PS; Mosquera JM; MacDonald TY; D'Alfonso TM; Rubin MA; Shin SJ
Hum Pathol; 2014 Apr; 45(4):709-16. PubMed ID: 24457083
[TBL] [Abstract][Full Text] [Related]
11. Cutaneous angiosarcoma and atypical vascular lesions of the skin and breast after radiation therapy for breast carcinoma.
Fineberg S; Rosen PP
Am J Clin Pathol; 1994 Dec; 102(6):757-63. PubMed ID: 7801888
[TBL] [Abstract][Full Text] [Related]
12. The utility of MYC and FLT4 in the diagnosis and treatment of postradiation atypical vascular lesion and angiosarcoma of the breast.
Cornejo KM; Deng A; Wu H; Cosar EF; Khan A; St Cyr M; Tomaszewicz K; Dresser K; O'Donnell P; Hutchinson L
Hum Pathol; 2015 Jun; 46(6):868-75. PubMed ID: 25864386
[TBL] [Abstract][Full Text] [Related]
13. Radiation-associated cutaneous atypical vascular lesions and angiosarcoma: clinicopathologic analysis of 42 cases.
Brenn T; Fletcher CD
Am J Surg Pathol; 2005 Aug; 29(8):983-96. PubMed ID: 16006792
[TBL] [Abstract][Full Text] [Related]
14. FISH for MYC amplification and anti-MYC immunohistochemistry: useful diagnostic tools in the assessment of secondary angiosarcoma and atypical vascular proliferations.
Fernandez AP; Sun Y; Tubbs RR; Goldblum JR; Billings SD
J Cutan Pathol; 2012 Feb; 39(2):234-42. PubMed ID: 22121953
[TBL] [Abstract][Full Text] [Related]
15. Angiosarcoma, radiation-associated angiosarcoma, and atypical vascular lesion.
Lucas DR
Arch Pathol Lab Med; 2009 Nov; 133(11):1804-9. PubMed ID: 19886715
[TBL] [Abstract][Full Text] [Related]
16. Postradiation cutaneous vascular tumors of the breast: a review.
Weaver J; Billings SD
Semin Diagn Pathol; 2009 Aug; 26(3):141-9. PubMed ID: 20043513
[TBL] [Abstract][Full Text] [Related]
17. Radiation-induced vascular lesions of the skin: an overview.
Flucke U; Requena L; Mentzel T
Adv Anat Pathol; 2013 Nov; 20(6):407-15. PubMed ID: 24113311
[TBL] [Abstract][Full Text] [Related]
18. MYC and NOTCH1-positive postradiation cutaneous angiosarcoma of the breast.
Sheu TG; Hunt KK; Middleton LP
Breast J; 2021 Mar; 27(3):264-267. PubMed ID: 33527629
[TBL] [Abstract][Full Text] [Related]
19. Radiation-induced breast angiosarcoma with a confirmative feature of c-MYC amplification.
Tajima S; Mochizuki R; Sugimura H; Hoshi S
Jpn J Clin Oncol; 2014 Jul; 44(7):702-3. PubMed ID: 24903854
[No Abstract] [Full Text] [Related]
20. [Post-radiation atypical vascular lesions and angiosarcoma: 11 cases].
Karkouche R; Carbonnelle-Puscian A; Rivet J; Fraitag S; Moulonguet I; Carlotti A; Havard S; Vérola O; Cavelier-Balloy B
Ann Dermatol Venereol; 2012 Feb; 139(2):109-17. PubMed ID: 22325749
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]